Long-term outcomes of patients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease following solid organ transplant or allogeneic hematopoietic cell transplant treated with tabelecleucel in a multicenter expanded access program study Meeting Abstract
| Authors: | Prockop, S. E.; Reshef, R.; Tsai, D. E.; Bunin, N.; Abu-Arja, R.; Mahadeo, K. M.; Weng, W. K.; van Besien, K.; Loeb, D.; Nasta, S. D.; Nemecek, E. R.; Hiremath, M.; Yue, S.; Sun, Y.; Navarro, W. H.; Nikiforow, S. |
| Abstract Title: | Long-term outcomes of patients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease following solid organ transplant or allogeneic hematopoietic cell transplant treated with tabelecleucel in a multicenter expanded access program study |
| Meeting Title: | Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 26 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2020 Feb 19-23 |
| Meeting Location: | Orlando, FL |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-03-01 |
| Start Page: | S61 |
| End Page: | S62 |
| Language: | English |
| ACCESSION: | WOS:000516887900082 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2019.12.228 |
| Notes: | Meeting Abstract: 81 -- Source: Wos |
